
Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

DeFi Technologies' Subsidiary Valour Strengthens Nordic Market Strategy with Transfer of Crypto ETPs to Spotlight Stock Market

The 16th China Jiangbei Watertown and Pearl of Two Rivers (Liaocheng) Gourd Culture Art Festival Was Held
